| Literature DB >> 28676970 |
Mayara Sandrielly Pereira Soares1, Cassiana Macagnan Viau2, Jenifer Saffi2, Marcelo Zanusso Costa3, Tatiane Morgana da Silva3, Pathise Souto Oliveira3, Juliana Hofstatter Azambuja4, Alethéa Gatto Barschak4, Elizandra Braganhol4, Angela T S Wyse5, Roselia Maria Spanevello6, Francieli Moro Stefanello7.
Abstract
High plasma levels of methionine (Met) and its metabolites such as methionine sulfoxide (MetO) may occur in several genetic abnormalities. Patients with hypermethioninemia can present neurological dysfunction; however, the neurotoxicity mechanisms induced by these amino acids remain unknown. The aim of the present work was to study the effects of Met and/or MetO on oxidative stress, genotoxicity, cytotoxicity and to evaluate whether the cell death mechanism is mediated by apoptosis in the cerebral cortex of young rats. Forty-eight Wistar rats were divided into groups: saline, Met 0.4 g/Kg, MetO 0.1 g/Kg and Met 0.4 g/Kg + MetO 0.1 g/Kg, and were euthanized 1 and 3 h after subcutaneous injection. Results showed that TBARS levels were enhanced by MetO and Met+MetO 1 h and 3 h after treatment. ROS was increased at 3 h by Met, MetO and Met+MetO. SOD activity was increased in the Met group, while CAT was reduced in all experimental groups 1 h and 3 h after treatment. GPx activity was enhanced 1 h after treatment by Met, MetO and Met+MetO, however it was reduced in the same experimental groups 3 h after administration of amino acids. Caspase-3, caspase-9 and DNA damage was increased and cell viability was reduced by Met, MetO and Met+MetO at 3 h. Also, Met, MetO and Met+MetO, after 3 h, enhanced early and late apoptosis cells. Mitochondrial electrochemical potential was decreased by MetO and Met+MetO 1 h and 3 h after treatment. These findings help understand the mechanisms involved in neurotoxicity induced by hypermethioninemia.Entities:
Keywords: DNA damage; apoptosis; caspases; methionine; methionine sulfoxide; oxidative stress
Mesh:
Substances:
Year: 2017 PMID: 28676970 DOI: 10.1007/s11011-017-0054-9
Source DB: PubMed Journal: Metab Brain Dis ISSN: 0885-7490 Impact factor: 3.584